Effectiveness of empirical <i>Helicobacter pylori</i> eradication therapy with furazolidone in Russia: results from the European Registry on <i>Helicobacter pylori</i> Management (Hp-EuReg)

Background. First-line therapy does not always provide a high level of Helicobacter pylori eradication due to the increase of H. pylori resistance to antibiotics; therefore, it remains necessary to identify the most effective rescue treatments. The purpose of this study was to evaluate the efficacy...

Full description

Bibliographic Details

Published in:	Терапевтический архив
Main Authors:	Dmitry S. Bordin, Irina N. Voynovan, Aiman S. Sarsenbaeva, Oleg V. Zaytsev, Rustam A. Abdulkhakov, Natalia V. Bakulina, Igor G. Bakulin, Marina F. Osipenko, Maria A. Livzan, Sergei A. Alekseenko, Larisa V. Tarasova, Galina N. Tarasova, Pavel O. Bogomolov, Igor V. Maev, Dmitry N. Andreev, Sayar R. Abdulkhakov, Boris D. Starostin, Natalia V. Bakanova, Alla G. Kononova, Sergei V. Kolbasnikov, Elena L. Bueverova, Leticia Moreira, Francis Megraud, Colm O'Morain, Olga Perez Nyssen, Javier Perez Gisbert
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2023-03-01
Subjects:	helicobacter pylori eradication hp-eureg furazolidone sequential therapy adverse event
Online Access:	https://ter-arkhiv.ru/0040-3660/article/viewFile/321743/113259